Home
Insights
Team
Contact
Login
Insights: Healthcare
Policy
Energy
,
Financials
,
Healthcare
,
Housing
,
Infrastructure
,
Macro
,
Miscellaneous
,
Tech / Media / Telecom
State of the Union
President Trump will deliver his State of the Union (SOTU) speech next Tuesday, 2/24, and if precedent holds, is likely to issue his FY27 budget request by ~mid-March. The annual budget request provides a more granular overview of the administration’s policy priorities, and along with the speech, influences how the President’s allies in Congress...
Policy
Healthcare
340B Drug Discount Program
The White House Office of Management & Budget (OMB) is currently reviewing a proposed rule regarding the Health Resources and Services Administration’s (HRSA) 340B Rebate Pilot Program.
Policy
Healthcare
Democratic Drug Pricing Agenda
Democratic members of the Senate Finance Committee – including Ranking Member Wyden (D-OR) and Sens. Welch (D-VT), Cortez Masto (D-NV), and Gallego (D-AZ) – have released a high-level policy framework to lower drug prices.
Policy
Healthcare
ACA/PY27 Individual Market Regulations
The Centers for Medicare & Medicaid Services (CMS) issued the proposed “Notice of Benefit and Payment Parameters” for the plan year (PY) 2027. The rule sets standards for Affordable Care Act (ACA) coverage and the health insurance exchanges. Below is a high-level summary of the key attributes of the proposed rule that impact consumers, insurers,...
Policy
Healthcare
Drug Pricing/TrumpRx
The launch of the TrumpRx direct-to-consumer (DTC) platform has been delayed, though HHS Secretary Kennedy has indicated it could go live as soon as this month. There is speculation the delay is attributable to concerns relating to the Anti-Kickback Statute (AKS). To that end, in recent days, the HHS Office of Inspector General (OIG) issued a...
Policy
Healthcare
Medicare Drug Price Negotiations
CMS released the names of the 15 Parts B and D drugs subject to the third round of the Medicare drug price negotiation program established under the Inflation Reduction Act (IRA). Additionally, CMS announced the first drug already included in the program which will be subject to renegotiation.
Pages:
Previous
1
2
3
4
5
6
7
...
22
Next
↑